Angiotensin II Type 1 Receptor Blockers
This graph shows the total number of publications written about "Angiotensin II Type 1 Receptor Blockers" by people in the URMC Research Network by year, and whether "Angiotensin II Type 1 Receptor Blockers" was a major or minor topic of these publication.
Below are the most recent publications written about "Angiotensin II Type 1 Receptor Blockers" by people in Profiles.
-
Rajagopalan S, Arora A, Shafiq N, Reddy S S, Pandhi P, Mittal N, Malhotra S. Pharmacotherapy of heart failure with normal ejection fraction (HFNEF)--a systematic review. Br J Clin Pharmacol. 2011 Sep; 72(3):369-80.
-
Montalescot G, Drexler H, Gallo R, Pearson T, Thoenes M, Bhatt DL. Effect of irbesartan and enalapril in non-ST elevation acute coronary syndrome: results of the randomized, double-blind ARCHIPELAGO study. Eur Heart J. 2009 Nov; 30(22):2733-41.
-
Wong CS, Pierce CB, Cole SR, Warady BA, Mak RH, Benador NM, Kaskel F, Furth SL, Schwartz GJ. Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study. Clin J Am Soc Nephrol. 2009 Apr; 4(4):812-9.
-
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2006 May 16; 47(10):2130-9.
-
Shen WL, Gao PJ, Che ZQ, Ji KD, Yin M, Yan C, Berk BC, Zhu DL. NAD(P)H oxidase-derived reactive oxygen species regulate angiotensin-II induced adventitial fibroblast phenotypic differentiation. Biochem Biophys Res Commun. 2006 Jan 6; 339(1):337-43.
-
Watanabe T, Suzuki J, Yamawaki H, Sharma VK, Sheu SS, Berk BC. Losartan metabolite EXP3179 activates Akt and endothelial nitric oxide synthase via vascular endothelial growth factor receptor-2 in endothelial cells: angiotensin II type 1 receptor-independent effects of EXP3179. Circulation. 2005 Sep 20; 112(12):1798-805.
-
Watanabe T, Barker TA, Berk BC. Angiotensin II and the endothelium: diverse signals and effects. Hypertension. 2005 Feb; 45(2):163-9.
-
Berk BC, Bisognano JD. VALUE in hypertension treatment. Curr Hypertens Rep. 2004 Dec; 6(6):411-3.
-
Bisognano J, McLaughlin T, Roberts CS, Battleman D, Schwartz B, Garza D, Tang S. Incremental effectiveness of amlodipine besylate in the treatment of hypertension with single and multiple medication regimens. Am J Hypertens. 2004 Aug; 17(8):676-83.
-
Thai H, Wollmuth J, Goldman S, Gaballa M. Angiotensin subtype 1 rReceptor (AT1) blockade improves vasorelaxation in heart failure by up-regulation of endothelial nitric-oxide synthase via activation of the AT2 receptor. J Pharmacol Exp Ther. 2003 Dec; 307(3):1171-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
